SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MYL -Mylan
An SI Board Since May 1999
Posts SubjectMarks Bans
9 0 0
Emcee:  Spekulatius Type:  Unmoderated
Mylan is one of the largest and most renown generics companies. I consider the generics business to be very attractive, with major blockbusters losing their patent protection. The growth rates of generics should exceed the growth rates of the proprietary products which should bode well for Mylan. As one of the largests generic companies, Mylan should be able to achieve a 20% sales and earnings growth.
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
9 As usual - wait and see <G> Judy-11/21/1999
8 Hi Judy, If the prospect for better earnings is there then the stock ought tArnieC-11/20/1999
7 Hi Ralf, No, I am not counting on them beating earnings and agree with you on mJudy-11/17/1999
6 I would not bet on MYL beating earning estimates. Revenues have only been growiSpekulatius-11/16/1999
5 Hi Arnie, Not all stocks make a cup and handle. I think this one will go a liJudy-11/16/1999
4 Judy, Mylan has a ways to go if its going to form a cup and handle and break ouArnieC-11/15/1999
3 No it hasn't Arnie. Was very disappointed with it today too. Things not lJudy-11/12/1999
2 Mylan is expected to have good growth on-going. Will they beat the consensus ofArnieC-11/10/1999
1 Hi, I agree with much of what you posted. The stock is really IMO undervaluedJudy-5/13/1999
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):